Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's Disease.


Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
2020
Historique:
pubmed: 24 5 2020
medline: 16 9 2021
entrez: 24 5 2020
Statut: ppublish

Résumé

Optimal management in expert centers for Parkinson's disease (PD) usually involves pharmacological and non-pharmacological interventions, delivered by a multidisciplinary approach. However, there is no guideline specifying how this model should be organized. Consequently, the nature of multidisciplinary care varies widely. To optimize care delivery, we aimed to provide recommendations for the organization of multidisciplinary care in PD. Twenty expert centers in the field of multidisciplinary PD care participated. Their leading neurologists completed a survey covering eight themes: elements for optimal multidisciplinary care; team members; role of patients and care partners; team coordination; team meetings; inpatient versus outpatient care; telehealth; and challenges towards multidisciplinary care. During a consensus meeting, outcomes were incorporated into concept recommendations that were reviewed by each center's multidisciplinary team. Three patient organizations rated the recommendations according to patient priorities. Based on this feedback, a final set of recommendations (essential elements for delivery of multidisciplinary care) and considerations (desirable elements) was developed. We developed 30 recommendations and 10 considerations. The patient organizations rated the following recommendations as most important: care is organized in a patient-centered way; every newly diagnosed patient has access to a core multidisciplinary team; and each team has a coordinator. A checklist was created to further facilitate its implementation. We provide a practical tool to improve multidisciplinary care for persons with PD at the organizational level. Future studies should focus on implementing these recommendations in clinical practice, evaluating their potential applicability and effectiveness, and comparing alternative models of PD care.

Sections du résumé

BACKGROUND
Optimal management in expert centers for Parkinson's disease (PD) usually involves pharmacological and non-pharmacological interventions, delivered by a multidisciplinary approach. However, there is no guideline specifying how this model should be organized. Consequently, the nature of multidisciplinary care varies widely.
OBJECTIVE
To optimize care delivery, we aimed to provide recommendations for the organization of multidisciplinary care in PD.
METHODS
Twenty expert centers in the field of multidisciplinary PD care participated. Their leading neurologists completed a survey covering eight themes: elements for optimal multidisciplinary care; team members; role of patients and care partners; team coordination; team meetings; inpatient versus outpatient care; telehealth; and challenges towards multidisciplinary care. During a consensus meeting, outcomes were incorporated into concept recommendations that were reviewed by each center's multidisciplinary team. Three patient organizations rated the recommendations according to patient priorities. Based on this feedback, a final set of recommendations (essential elements for delivery of multidisciplinary care) and considerations (desirable elements) was developed.
RESULTS
We developed 30 recommendations and 10 considerations. The patient organizations rated the following recommendations as most important: care is organized in a patient-centered way; every newly diagnosed patient has access to a core multidisciplinary team; and each team has a coordinator. A checklist was created to further facilitate its implementation.
CONCLUSION
We provide a practical tool to improve multidisciplinary care for persons with PD at the organizational level. Future studies should focus on implementing these recommendations in clinical practice, evaluating their potential applicability and effectiveness, and comparing alternative models of PD care.

Identifiants

pubmed: 32444563
pii: JPD202078
doi: 10.3233/JPD-202078
pmc: PMC7415700
mid: NIHMS1605525
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1087-1098

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS097615
Pays : United States
Organisme : NINDS NIH HHS
ID : L30 NS084235
Pays : United States

Références

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S119-22
pubmed: 26372623
JAMA Neurol. 2013 May;70(5):565-70
pubmed: 23479138
Parkinsonism Relat Disord. 2012 Nov;18(9):1011-6
pubmed: 22704902
Int Rev Neurobiol. 2017;134:1257-1281
pubmed: 28805572
J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):158-62
pubmed: 12531939
Mov Disord. 2007 Aug 15;22(11):1528-37
pubmed: 17523198
J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):828-835
pubmed: 29321141
Neurology. 2016 Jun 14;86(24):2278-83
pubmed: 27170564
Neurology. 2016 Apr 5;86(14 Suppl 1):S3-12
pubmed: 27044648
Mov Disord. 2015 Jul;30(8):1050-8
pubmed: 26095443
Lancet Neurol. 2010 Jan;9(1):46-54
pubmed: 19959398
Community Ment Health J. 1968 Dec;4(6):443-53
pubmed: 24185570
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S219-23
pubmed: 20082995
Lancet Neurol. 2013 Oct;12(10):947-56
pubmed: 23988337
BMC Health Serv Res. 2004 Jul 01;4(1):15
pubmed: 15230977
Lancet Neurol. 2014 Jun;13(6):557-66
pubmed: 24726066
JAMA Neurol. 2018 Mar 1;75(3):271-272
pubmed: 29297000
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002812
pubmed: 22895930
BMJ. 2014 Mar 19;348:g1838
pubmed: 24647365
Postgrad Med J. 2011 Sep;87(1031):575-8
pubmed: 21862501
Int J Integr Care. 2013 Mar 22;13:e010
pubmed: 23687482
J Am Geriatr Soc. 2018 Jul;66(6):1226-1232
pubmed: 29608779
Int Rev Neurobiol. 2017;132:511-523
pubmed: 28554420
Mov Disord. 2016 Sep;31(9):1258-62
pubmed: 27501323
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002817
pubmed: 22786482
J Neurol. 2018 Apr;265(4):764-773
pubmed: 29392459
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S167-73
pubmed: 24262173
Lancet. 2009 Jun 13;373(9680):2055-66
pubmed: 19524782
Neurol Clin Pract. 2016 Jun;6(3):241-251
pubmed: 27347441
Mov Disord. 2009 Jan 30;24(2):282-6
pubmed: 19170189

Auteurs

Danique L M Radder (DLM)

Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour; Department of Neurology, Nijmegen, The Netherlands.

Jorik Nonnekes (J)

Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Rehabilitation; Nijmegen, The Netherlands.

Marlies van Nimwegen (M)

Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour; Department of Neurology, Nijmegen, The Netherlands.

Carsten Eggers (C)

Department of Neurology, University Hospital of Marburg, Marburg, Germany.

Giovanni Abbruzzese (G)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal Child Health, University of Genoa - IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Guido Alves (G)

The Norwegian Center for Movement Disorders, Department of Neurology, Stavanger University Hospital, Stavanger, Norway.

Nina Browner (N)

University of North Carolina, Movement Disorders Center, Chapel Hill, NC, USA.

K Ray Chaudhuri (KR)

Institute of Psychiatry, Psychology & Neuroscience, Parkinson Foundation International Center of Excellence, King's College Hospital, Denmark Hill, London, UK.

Georg Ebersbach (G)

Movement Disorder Clinic Beelitz-Heilstaetten, Beelitz, Germany.

Joaquim J Ferreira (JJ)

Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
CNS - Campus Neurológico Sénior, Torres Vedras, Portugal.

Jori E Fleisher (JE)

Rush University Medical Center, Chicago, IL, USA.

Peter Fletcher (P)

Cheltenham General Hospital, Gloucestershire, UK.

Giuseppe Frazzitta (G)

Moriggia-Pelascini Hospital, Gravedona ed Uniti, Gravedona, Italy.

Nir Giladi (N)

Neurological Institute, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University, Tel Aviv, Israel.

Mark Guttman (M)

Center for Movement Disorders, Toronto, Canada.

Robert Iansek (R)

Kingston Center Monash Health, Melbourne, Australia.

Suketu Khandhar (S)

Kaiser Permanente Sacramento Medical Center, Sacramento, CA, USA.

Jochen Klucken (J)

Department of Molecular Neurology, University Hospital Erlangen, Erlangen, Germany.
Research Group Digital Health Pathways, Fraunhofer IIS, Erlangen, Germany.

Anne-Louise Lafontaine (AL)

Department of Neurology and Neurosurgery, McGill Movement Disorders Clinic, McGill University, Montreal, Canada.

Connie Marras (C)

The Edmond J Safra Program in Parkinson's disease and the Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Canada.

John Nutt (J)

Oregon & Health Science University Hospital, Portland, OR, USA.

Michael S Okun (MS)

University of Florida Department of Neurology, Fixel Center for Neurological Diseases, Program for Movement Disorders and Neurorestoration, Gainesville, FL, USA.

Sotirios A Parashos (SA)

Struthers Parkinson's Center, Golden Valley, MN, USA.

Marten Munneke (M)

Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour; Department of Neurology, Nijmegen, The Netherlands.

Bastiaan R Bloem (BR)

Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour; Department of Neurology, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH